Jane Street Group, LLC Kempharm, Inc Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	SELL	N/A	-23,000 Reduced 69.7%	10,000 $49,000
Q3 2024 Nov 14, 2024	BUY	N/A	33,000 New	33,000 $163,000
Q4 2021 Feb 15, 2022	SELL	$7.6 - $10.26 $213,560 - $288,306	-28,100 Reduced 30.35%	64,500 $562,000
Q3 2021 Nov 16, 2021	SELL	$8.72 - $13.31 $1.1 Million - $1.68 Million	-126,000 Reduced 57.64%	92,600 $864,000
Q2 2021 Aug 16, 2021	SELL	$8.52 - $15.47 $1.48 Million - $2.69 Million	-174,000 Reduced 44.32%	218,600 $2.8 Million
Q1 2021 May 18, 2021	BUY	$5.6 - $13.47 $2.2 Million - $5.29 Million	392,600 New	392,600 $3.61 Million

112

29.9M

418K

43K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.